Motomu Hashimoto

44PUBLICATIONS
143CO-AUTHORS
Respiratory diseasesPodiatryClinical pharmacology and therapeuticsAutoimmunityPlant pathology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Sep 28, 2026
Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study.

|Jun 19, 2026
Real-world clinical outcomes of patients with disproportionate articular pain in rheumatoid arthritis: ANSWER cohort study.

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Dec 12, 2025
Rituximab versus intravenous cyclophosphamide for anti-neutrophil cytoplasmic antibody-associated vasculitis with severe renal impairment: A multicentre REVEAL cohort study.

Hirofumi Miyake, Ayana Okazaki, Shogo Matsuda

|Nov 11, 2025
Lupus podocytopathy as a first renal manifestation in long-standing systemic lupus erythematosus: a case report.

Tasuku Togashi, Yuhei Fujisawa, Yuya Yano

|Oct 29, 2025
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.

Yuji Nozaki, Koichi Murata, Akira Onishi

Pageof 8

Frequent Collaborators

19 joint publications

Koichi Murata

18 joint publications

Wataru Yamamoto

16 joint publications

Akira Onishi

14 joint publications

Kosuke Ebina